Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000328908 | SCV000334764 | benign | not specified | 2015-09-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000892015 | SCV001035868 | benign | Spondyloepimetaphyseal dysplasia, PAPSS2 type | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003422192 | SCV004127029 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | PAPSS2: BP4, BP7 |
Breakthrough Genomics, |
RCV003422192 | SCV005319833 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003909941 | SCV004724750 | likely benign | PAPSS2-related disorder | 2019-06-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |